European Companies Search Engine
8 EU fundings (€256,320): Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases … BdlYear 2019 EU Research and Innovation programme "Horizon"
Text
Crossroads Bank for Enterprises (KBO) 0543.573.053
This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: UCB Biopharma B.V., Anderlecht, Belgium.
The visualizations for "8 EU fundings (€256,320): Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases …"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.